IFNA2 and B-cell non-Hodgkin lymphoma: For the treatment of follicular lymphoma, a kind of indolent B-cell lymphoma, the combination of IFN-α2b with traditional chemotherapeutic drugs was proven to induce a good response, such as the cyclophosphamide + vincristine + prednisone (CVP) + IFN-α2b regimen followed by IFN-α2b maintenance therapy [192, 193].